These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26049400)

  • 1. A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control.
    Yousri NA; Mook-Kanamori DO; Selim MM; Takiddin AH; Al-Homsi H; Al-Mahmoud KA; Karoly ED; Krumsiek J; Do KT; Neumaier U; Mook-Kanamori MJ; Rowe J; Chidiac OM; McKeon C; Al Muftah WA; Kader SA; Kastenmüller G; Suhre K
    Diabetologia; 2015 Aug; 58(8):1855-67. PubMed ID: 26049400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control.
    Mook-Kanamori DO; Selim MM; Takiddin AH; Al-Homsi H; Al-Mahmoud KA; Al-Obaidli A; Zirie MA; Rowe J; Yousri NA; Karoly ED; Kocher T; Sekkal Gherbi W; Chidiac OM; Mook-Kanamori MJ; Abdul Kader S; Al Muftah WA; McKeon C; Suhre K
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E479-83. PubMed ID: 24423354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
    Peddinti G; Cobb J; Yengo L; Froguel P; Kravić J; Balkau B; Tuomi T; Aittokallio T; Groop L
    Diabetologia; 2017 Sep; 60(9):1740-1750. PubMed ID: 28597074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of exercise on diurnal and nocturnal markers of glycaemic variability and oxidative stress in obese individuals with type 2 diabetes or impaired glucose tolerance.
    Farabi SS; Carley DW; Smith D; Quinn L
    Diab Vasc Dis Res; 2015 Sep; 12(5):381-5. PubMed ID: 25994591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-based approach for analyzing intra- and interfluid metabolite associations in human blood, urine, and saliva.
    Do KT; Kastenmüller G; Mook-Kanamori DO; Yousri NA; Theis FJ; Suhre K; Krumsiek J
    J Proteome Res; 2015 Feb; 14(2):1183-94. PubMed ID: 25434815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum to: A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control.
    Yousri NA; Mook-Kanamori DO; El-Din Selim MM; Takiddin AH; Al-Homsi H; Al-Mahmoud KA; Karoly ED; Krumsiek J; Do KT; Neumaier U; Mook-Kanamori MJ; Rowe J; Chidiac OM; McKeon C; Al Muftah WA; Kader SA; Kastenmüller G; Suhre K
    Diabetologia; 2015 Sep; 58(9):2199. PubMed ID: 26133943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative analysis of dependence of saliva sorbitol and fructosamine levels on blood glucose level in patients with diabetes].
    Morenkova SA
    Biomed Khim; 2004; 50(6):612-4. PubMed ID: 15707277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide assessment of diabetes mellitus in Qatari identifies IGFBP-2 as a risk factor already with early glycaemic disturbances.
    Noordam R; van Heemst D; Suhre K; Krumsiek J; Mook-Kanamori DO
    Arch Biochem Biophys; 2020 Aug; 689():108476. PubMed ID: 32585310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and impaired glucose tolerance are associated with word memory source monitoring recollection deficits but not simple recognition familiarity deficits following water, low glycaemic load, and high glycaemic load breakfasts.
    Lamport DJ; Lawton CL; Mansfield MW; Moulin CA; Dye L
    Physiol Behav; 2014 Jan; 124():54-60. PubMed ID: 24184411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus.
    Holub I; Gostner A; Hessdörfer S; Theis S; Bender G; Willinger B; Schauber J; Melcher R; Allolio B; Scheppach W
    Horm Metab Res; 2009 Dec; 41(12):886-92. PubMed ID: 19701877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes.
    Kaur P; Rizk N; Ibrahim S; Luo Y; Younes N; Perry B; Dennis K; Zirie M; Luta G; Cheema AK
    Mol Biosyst; 2013 Feb; 9(2):307-17. PubMed ID: 23247761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring.
    Jin SM; Kim TH; Oh S; Baek J; Joung JY; Park SM; Cho YY; Sohn SY; Hur KY; Lee MS; Lee MK; Kim JH
    Diabet Med; 2015 Feb; 32(2):274-9. PubMed ID: 25307609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
    Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
    Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.
    Xu F; Tavintharan S; Sum CF; Woon K; Lim SC; Ong CN
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1060-5. PubMed ID: 23633210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glomerular and tubular dysfunction with glycaemic control, lipid, lipoprotein, apolipoprotein and antioxidant status in type 2 diabetes mellitus.
    Farvid MS; Djalali M; Siassi F; Farvid SS
    Singapore Med J; 2007 Sep; 48(9):840-6. PubMed ID: 17728966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes.
    Mussell M; Hewer W; Kulzer B; Bergis K; Rist F
    Diabet Med; 2004 Nov; 21(11):1253-6. PubMed ID: 15498095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.